STRATA Skin Sciences, Inc. financial data

Symbol
SSKN on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
MELA SCIENCES, INC. /NY (to 1/4/2016), ELECTRO OPTICAL SCIENCES INC /NY (to 4/30/2010)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 137 % +12.6%
Quick Ratio 34.2 % -2.81%
Debt-to-equity 234 % +62.4%
Return On Equity -82.3 % -198%
Return On Assets -24.6 % -118%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.1M shares +0.52%
Common Stock, Shares, Outstanding 35.1M shares +0.52%
Entity Public Float 17.3M USD +0.24%
Common Stock, Value, Issued 35K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.1M shares +0.57%
Weighted Average Number of Shares Outstanding, Diluted 35.1M shares +0.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.5M USD -11.3%
Cost of Revenue 15.4M USD +5%
Research and Development Expense 1.24M USD +5.25%
Selling and Marketing Expense 12.2M USD -20.7%
General and Administrative Expense 10.3M USD -0.49%
Costs and Expenses 26.1M USD -3.34%
Operating Income (Loss) -8.91M USD -80.6%
Nonoperating Income (Expense) -2.55M USD -187%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.9M USD -99.1%
Income Tax Expense (Benefit) -92K USD -246%
Net Income (Loss) Attributable to Parent -11.4M USD -93.2%
Earnings Per Share, Basic -0.33 USD/shares -94.1%
Earnings Per Share, Diluted -0.33 USD/shares -94.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.24M USD +85.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.63M USD -7.87%
Inventory, Net 2.7M USD -52.7%
Assets, Current 13.2M USD -8.77%
Property, Plant and Equipment, Net 11.7M USD +43.3%
Operating Lease, Right-of-Use Asset 1.51M USD +73.3%
Intangible Assets, Net (Excluding Goodwill) 6.83M USD -59.1%
Goodwill 6.52M USD -25.9%
Other Assets, Noncurrent 231K USD +182%
Assets 40M USD -18.5%
Accounts Payable, Current 3.59M USD +15.9%
Employee-related Liabilities, Current 1.67M USD -23%
Accrued Liabilities, Current 6.27M USD -4.28%
Contract with Customer, Liability, Current 2.37M USD -7.14%
Liabilities, Current 12.6M USD -3.6%
Contract with Customer, Liability, Noncurrent 377K USD +64.6%
Deferred Income Tax Liabilities, Net 186K USD -39.2%
Operating Lease, Liability, Noncurrent 1.17M USD +138%
Liabilities 30.6M USD +2.73%
Retained Earnings (Accumulated Deficit) -241M USD -4.94%
Stockholders' Equity Attributable to Parent 9.43M USD -51.2%
Liabilities and Equity 40M USD -18.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -804K USD +1.59%
Net Cash Provided by (Used in) Financing Activities -18K USD
Net Cash Provided by (Used in) Investing Activities -725K USD +59.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 35.1M shares +0.52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.55M USD +40.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.57M USD +57%
Interest Paid, Excluding Capitalized Interest, Operating Activities 480K USD +99.2%
Deferred Tax Assets, Valuation Allowance 50.1M USD +2.31%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 51.2M USD +1.62%
Operating Lease, Liability 1.47M USD +68.5%
Depreciation 2.98M USD +21.5%
Payments to Acquire Property, Plant, and Equipment 725K USD -59.5%
Lessee, Operating Lease, Liability, to be Paid 1.96M USD +103%
Property, Plant and Equipment, Gross 36.7M USD +20%
Operating Lease, Liability, Current 300K USD -21.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 334K USD +71.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 463K USD +19.9%
Deferred Income Tax Expense (Benefit) -120K USD -400%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 494K USD +415%
Lessee, Operating Lease, Liability, to be Paid, Year Three 290K USD +427%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -68K USD -396%
Current Income Tax Expense (Benefit) 28K USD +21.7%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 301K USD
Operating Lease, Payments 416K USD +8.62%
Additional Paid in Capital 251M USD +0.59%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 28K USD +21.7%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 2.47M USD -15.4%
Depreciation, Depletion and Amortization 5.41M USD -10.9%
Deferred Tax Assets, Net of Valuation Allowance 1.05M USD -23.3%
Share-based Payment Arrangement, Expense 112K USD -65.5%
Deferred State and Local Income Tax Expense (Benefit) -52K USD -406%
Interest Expense 1.88M USD +85.4%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%